The rational clinical examination. Does this patient have a mole or a melanoma?

Lifetime risk for malignant melanoma has increased from 1 in 1500 in the United States in 1930 to 1 in 75 projected for the year 2000. Because the tumor's thickness at excision is the primary prognostic determinant, early detection through the history and physical examination can play an important role in the patient's clinical course. Two checklists have been developed as diagnostic aids, the ABCD (A indicates asymmetry; B, border irregularity; C, irregular color; and D, diameter >6 mm) and the revised 7-point checklists. These checklists should be interpreted with some discretion, but 2 studies have found the sensitivity for the ABCD checklist to be 92% (95% confidence interval [CI], 82%-96%) and 100% (95% CI, 54%-100%); 1 study found the specificity to be 98% (95% CI, 95%-99%). The revised 7-point checklist has been reported to have a sensitivity of 79% (95% CI, 70%-85%) to 100% (95% CI, 94%-100%) and specificity of 30% (95% CI, 21%-39%) to 37% (95% CI, 28%-46%). Physicians' global assessments for detecting the presence or absence of melanoma are estimated to have a specificity of 96% to 99%, while sensitivity ranges widely from 50% to 97%. Nondermatologists' examinations appear to be less sensitive than examinations performed by dermatologists.

[1]  A. Halpern,et al.  Screening and surveillance of patients at high risk for malignant melanoma result in detection of earlier disease. , 1990, Journal of the American Academy of Dermatology.

[2]  B Gerbert,et al.  Primary care physicians as gatekeepers in managed care. Primary care physicians' and dermatologists' skills at secondary prevention of skin cancer. , 1996, Archives of dermatology.

[3]  J. R. Landis,et al.  The measurement of observer agreement for categorical data. , 1977, Biometrics.

[4]  Gary S. Rogers,et al.  Diagnosis and Treatment of Early Melanoma: NIH Consensus Development Panel on Early Melanoma , 1992 .

[5]  C. Grin,et al.  Prospective follow-up for malignant melanoma in patients with atypical-mole (dysplastic-nevus) syndrome. , 1991, The Journal of dermatologic surgery and oncology.

[6]  M. Litaker,et al.  Clinical predictors of malignant pigmented lesions. A comparison of the Glasgow seven-point checklist and the American Cancer Society's ABCDs of pigmented lesions. , 1992, The Journal of dermatologic surgery and oncology.

[7]  W. Clark,et al.  High risk of malignant melanoma in melanoma-prone families with dysplastic nevi. , 1985, Annals of internal medicine.

[8]  M. Skolnick,et al.  Interobserver concordance in discriminating clinical atypia of melanocytic nevi, and correlations with histologic atypia. , 1996, Journal of the American Academy of Dermatology.

[9]  W. McCarthy,et al.  Small-diameter malignant melanoma: a common diagnosis in New South Wales, Australia. , 1992, Journal of the American Academy of Dermatology.

[10]  E. R. Farmer,et al.  NIH Consensus conference. Diagnosis and treatment of early melanoma. , 1992, JAMA.

[11]  R. Mcgee,et al.  The recognition and management of melanoma and other skin lesions by general practitioners in New Zealand. , 1994, The New Zealand medical journal.

[12]  Alfred W. Kopf,et al.  Dysplastic nevi , 1989 .

[13]  J. Kirkwood,et al.  Interclinician agreement on the recognition of selected gross morphologic features of pigmented lesions. Studies of melanocytic nevi V. , 1992, Journal of the American Academy of Dermatology.

[14]  M. Lebwohl,et al.  Importance of complete cutaneous examination for the detection of malignant melanoma. , 1986, Journal of the American Academy of Dermatology.

[15]  Robin Marks,et al.  Early detection of skin cancer , 1994, The Medical journal of Australia.

[16]  K. Welvaart,et al.  Screening for skin cancer in The Netherlands. , 1991, Acta dermato-venereologica.

[17]  M. G. Cook,et al.  Accuracy in clinically evaluating pigmented lesions. , 1989, BMJ.

[18]  A. Kopf,et al.  Dysplastic nevi. Markers for increased risk for melanoma. , 1989, Cancer.

[19]  M S Blois,et al.  Clinical characteristics of early cutaneous melanoma , 1980, Cancer.

[20]  A. Kopf,et al.  Early detection of malignant melanoma: The role of physician examination and self‐examination of the skin , 1985, CA: a cancer journal for clinicians.

[21]  R. MacKie,et al.  Clinical recognition of early invasive malignant melanoma. , 1990, BMJ.

[22]  D. Rigel,et al.  Evaluation of the American Academy of Dermatology's National Skin Cancer Early Detection and Screening Program. , 1996, Journal of the American Academy of Dermatology.

[23]  J. Bourke,et al.  An evaluation of the revised seven‐point checklist for the early diagnosis of cutaneous malignant melanoma , 1994, The British journal of dermatology.

[24]  E.M. HIGGINS,et al.  The application of the seven‐point check‐list in the assessment of benign pigmented lesions , 1992, Clinical and experimental dermatology.

[25]  R. Lew,et al.  Who discovers melanoma? Patterns from a population-based survey. , 1992, Journal of the American Academy of Dermatology.

[26]  Irene Gage,et al.  Evaluation of melanoma/skin cancer screening in Massachusetts. Preliminary results , 1990, Cancer.

[27]  C. Grin,et al.  Accuracy in the clinical diagnosis of malignant melanoma. , 1990, Archives of dermatology.

[28]  H. C. Williams,et al.  How do malignant melanomas present and does this correlate with the seven‐point check‐list? , 1991, Clinical and experimental dermatology.

[29]  P. Duray,et al.  Usefulness of frequent skin examination for the early detection of second primary cutaneous melanoma. , 1989, Cancer detection and prevention.

[30]  A. Kopf,et al.  The incidence of malignant melanoma in the United States: issues as we approach the 21st century. , 1996, Journal of the American Academy of Dermatology.

[31]  E J Lusk,et al.  How well do physicians recognize melanoma and other problem lesions? , 1986, Journal of the American Academy of Dermatology.

[32]  J C Briggs,et al.  Cutaneous melanoma. , 1993, Journal of the American Academy of Dermatology.

[33]  D. Ramsay,et al.  The ability of primary care physicians to recognize the common dermatoses. , 1981, Archives of dermatology.

[34]  D. Simel,et al.  Does the clinical examination predict airflow limitation? , 1995, JAMA.

[35]  M C Mihm,et al.  Cutaneous malignant melanoma: Prognostic guidelines for physicians and patients , 1982, CA: a cancer journal for clinicians.

[36]  A Halpern,et al.  Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma. , 1997, JAMA.

[37]  M Keefe,et al.  A study of the value of the seven‐point checklist in distinguishing benign pigmented lesions from melanoma , 1990, Clinical and experimental dermatology.

[38]  R. Stern,et al.  Diagnosis and treatment of nevomelanocytic lesions of the skin. A community-based study. , 1993, Archives of dermatology.

[39]  L. Hubener,et al.  Malignant melanoma; a statistical review of clinical and histological diagnoses. , 1956, A.M.A. archives of dermatology.